Industrial - Machinery
Compare Stocks
4 / 10Stock Comparison
EPAC vs CAT vs EMR vs GWW
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Industrial - Machinery
Industrial - Distribution
EPAC vs CAT vs EMR vs GWW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Industrial - Machinery | Agricultural - Machinery | Industrial - Machinery | Industrial - Distribution |
| Market Cap | $1.87B | $417.57B | $79.14B | $58.39B |
| Revenue (TTM) | $616M | $70.75B | $18.32B | $18.38B |
| Net Income (TTM) | $90M | $9.42B | $2.44B | $1.78B |
| Gross Margin | 49.8% | 32.5% | 52.7% | 39.2% |
| Operating Margin | 21.2% | 16.6% | 19.8% | 14.2% |
| Forward P/E | 18.7x | 37.0x | 21.7x | 27.7x |
| Total Debt | $228M | $43.33B | $13.76B | $3.16B |
| Cash & Equiv. | $152M | $9.98B | $1.54B | $585M |
EPAC vs CAT vs EMR vs GWW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Enerpac Tool Group … (EPAC) | 100 | 198.4 | +98.4% |
| Caterpillar Inc. (CAT) | 100 | 747.1 | +647.1% |
| Emerson Electric Co. (EMR) | 100 | 231.5 | +131.5% |
| W.W. Grainger, Inc. (GWW) | 100 | 398.5 | +298.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EPAC vs CAT vs EMR vs GWW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EPAC carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 4.6%, EPS growth 9.0%, 3Y rev CAGR 2.6%
- PEG 0.11 vs EMR's 4.80
- 4.6% revenue growth vs EMR's 3.0%
- Lower P/E (18.7x vs 27.7x), PEG 0.11 vs 1.24
CAT is the clearest fit if your priority is long-term compounding.
- 12.3% 10Y total return vs GWW's 462.8%
- +178.6% vs EPAC's -17.7%
EMR is the clearest fit if your priority is dividends.
- 1.5% yield, 37-year raise streak, vs GWW's 0.8%
GWW is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 37 yrs, beta 0.87, yield 0.8%
- Lower volatility, beta 0.87, Low D/E 76.4%, current ratio 2.83x
- Beta 0.87, yield 0.8%, current ratio 2.83x
- Beta 0.87 vs EMR's 1.57
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.6% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (18.7x vs 27.7x), PEG 0.11 vs 1.24 | |
| Quality / Margins | 14.6% margin vs GWW's 9.7% | |
| Stability / Safety | Beta 0.87 vs EMR's 1.57 | |
| Dividends | 1.5% yield, 37-year raise streak, vs GWW's 0.8% | |
| Momentum (1Y) | +178.6% vs EPAC's -17.7% | |
| Efficiency (ROA) | 19.7% ROA vs EMR's 5.8%, ROIC 32.1% vs 8.2% |
EPAC vs CAT vs EMR vs GWW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EPAC vs CAT vs EMR vs GWW — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EPAC leads in 1 of 6 categories
GWW leads 1 • CAT leads 1 • EMR leads 1 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — EPAC and CAT and EMR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CAT is the larger business by revenue, generating $70.8B annually — 114.9x EPAC's $616M. Profitability is closely matched — net margins range from 14.6% (EPAC) to 9.7% (GWW). On growth, CAT holds the edge at +22.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $616M | $70.8B | $18.3B | $18.4B |
| EBITDAEarnings before interest/tax | $147M | $14.0B | $4.7B | $2.9B |
| Net IncomeAfter-tax profit | $90M | $9.4B | $2.4B | $1.8B |
| Free Cash FlowCash after capex | $102M | $11.4B | $3.1B | $1.4B |
| Gross MarginGross profit ÷ Revenue | +49.8% | +32.5% | +52.7% | +39.2% |
| Operating MarginEBIT ÷ Revenue | +21.2% | +16.6% | +19.8% | +14.2% |
| Net MarginNet income ÷ Revenue | +14.6% | +13.3% | +13.3% | +9.7% |
| FCF MarginFCF ÷ Revenue | +16.6% | +16.2% | +17.0% | +7.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.7% | +22.2% | +2.9% | +10.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -10.0% | +30.2% | +28.2% | +18.2% |
Valuation Metrics
EPAC leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 20.9x trailing earnings, EPAC trades at a 56% valuation discount to CAT's 47.7x P/E. Adjusting for growth (PEG ratio), EPAC offers better value at 0.12x vs EMR's 7.74x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.9B | $417.6B | $79.1B | $58.4B |
| Enterprise ValueMkt cap + debt − cash | $2.0B | $450.9B | $91.4B | $61.0B |
| Trailing P/EPrice ÷ TTM EPS | 20.89x | 47.66x | 34.97x | 34.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.74x | 36.99x | 21.70x | 27.70x |
| PEG RatioP/E ÷ EPS growth rate | 0.12x | 1.70x | 7.74x | 1.56x |
| EV / EBITDAEnterprise value multiple | 12.59x | 33.47x | 18.09x | 20.70x |
| Price / SalesMarket cap ÷ Revenue | 3.04x | 6.18x | 4.39x | 3.25x |
| Price / BookPrice ÷ Book value/share | 4.46x | 19.74x | 3.94x | 14.30x |
| Price / FCFMarket cap ÷ FCF | 20.39x | 40.64x | 29.67x | 43.87x |
Profitability & Efficiency
GWW leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CAT delivers a 47.5% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $12 for EMR. EPAC carries lower financial leverage with a 0.53x debt-to-equity ratio, signaling a more conservative balance sheet compared to CAT's 2.03x. On the Piotroski fundamental quality scale (0–9), GWW scores 8/9 vs CAT's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.9% | +47.5% | +12.1% | +43.1% |
| ROA (TTM)Return on assets | +11.0% | +10.0% | +5.8% | +19.7% |
| ROICReturn on invested capital | +21.7% | +15.9% | +8.2% | +32.1% |
| ROCEReturn on capital employed | +20.8% | +19.1% | +10.0% | +39.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.53x | 2.03x | 0.68x | 0.76x |
| Net DebtTotal debt minus cash | $76M | $33.4B | $12.2B | $2.6B |
| Cash & Equiv.Liquid assets | $152M | $10.0B | $1.5B | $585M |
| Total DebtShort + long-term debt | $228M | $43.3B | $13.8B | $3.2B |
| Interest CoverageEBIT ÷ Interest expense | 13.59x | 9.22x | 6.46x | 32.42x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $38,068 today (with dividends reinvested), compared to $12,835 for EPAC. Over the past 12 months, CAT leads with a +178.6% total return vs EPAC's -17.7%. The 3-year compound annual growth rate (CAGR) favors CAT at 62.1% vs EPAC's 14.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.2% | +50.5% | +4.4% | +23.1% |
| 1-Year ReturnPast 12 months | -17.7% | +178.6% | +27.7% | +18.8% |
| 3-Year ReturnCumulative with dividends | +50.6% | +325.7% | +76.2% | +85.3% |
| 5-Year ReturnCumulative with dividends | +28.4% | +280.7% | +59.1% | +167.8% |
| 10-Year ReturnCumulative with dividends | +40.2% | +1230.1% | +207.0% | +462.8% |
| CAGR (3Y)Annualised 3-year return | +14.6% | +62.1% | +20.8% | +22.8% |
Risk & Volatility
Evenly matched — CAT and GWW each lead in 1 of 2 comparable metrics.
Risk & Volatility
GWW is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than EMR's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CAT currently trades 96.4% from its 52-week high vs EPAC's 76.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 1.56x | 1.57x | 0.87x |
| 52-Week HighHighest price in past year | $46.39 | $931.35 | $165.15 | $1286.56 |
| 52-Week LowLowest price in past year | $33.66 | $322.90 | $109.53 | $906.52 |
| % of 52W HighCurrent price vs 52-week peak | +76.6% | +96.4% | +85.6% | +95.9% |
| RSI (14)Momentum oscillator 0–100 | 48.6 | 66.6 | 51.4 | 69.6 |
| Avg Volume (50D)Average daily shares traded | 374K | 2.4M | 2.8M | 237K |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EPAC as "Hold", CAT as "Buy", EMR as "Buy", GWW as "Hold". Consensus price targets imply 14.2% upside for EMR (target: $161) vs -5.2% for CAT (target: $851). For income investors, EMR offers the higher dividend yield at 1.49% vs EPAC's 0.11%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $37.00 | $850.50 | $161.31 | $1193.14 |
| # AnalystsCovering analysts | 19 | 53 | 41 | 38 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +0.7% | +1.5% | +0.8% |
| Dividend StreakConsecutive years of raises | 1 | 8 | 37 | 37 |
| Dividend / ShareAnnual DPS | $0.04 | $5.86 | $2.10 | $9.73 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.7% | +1.2% | +1.6% | +1.8% |
EPAC leads in 1 of 6 categories (Valuation Metrics). GWW leads in 1 (Profitability & Efficiency). 2 tied.
EPAC vs CAT vs EMR vs GWW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EPAC or CAT or EMR or GWW a better buy right now?
For growth investors, Enerpac Tool Group Corp.
(EPAC) is the stronger pick with 4. 6% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Enerpac Tool Group Corp. (EPAC) offers the better valuation at 20. 9x trailing P/E (18. 7x forward), making it the more compelling value choice. Analysts rate Caterpillar Inc. (CAT) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EPAC or CAT or EMR or GWW?
On trailing P/E, Enerpac Tool Group Corp.
(EPAC) is the cheapest at 20. 9x versus Caterpillar Inc. at 47. 7x. On forward P/E, Enerpac Tool Group Corp. is actually cheaper at 18. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Enerpac Tool Group Corp. wins at 0. 11x versus Emerson Electric Co. 's 4. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EPAC or CAT or EMR or GWW?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +280. 7%, compared to +28. 4% for Enerpac Tool Group Corp. (EPAC). Over 10 years, the gap is even starker: CAT returned +1230% versus EPAC's +40. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EPAC or CAT or EMR or GWW?
By beta (market sensitivity over 5 years), W.
W. Grainger, Inc. (GWW) is the lower-risk stock at 0. 87β versus Emerson Electric Co. 's 1. 57β — meaning EMR is approximately 80% more volatile than GWW relative to the S&P 500. On balance sheet safety, Enerpac Tool Group Corp. (EPAC) carries a lower debt/equity ratio of 53% versus 2% for Caterpillar Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EPAC or CAT or EMR or GWW?
By revenue growth (latest reported year), Enerpac Tool Group Corp.
(EPAC) is pulling ahead at 4. 6% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -14. 6% for Caterpillar Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EPAC or CAT or EMR or GWW?
Enerpac Tool Group Corp.
(EPAC) is the more profitable company, earning 15. 0% net margin versus 9. 5% for W. W. Grainger, Inc. — meaning it keeps 15. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EPAC leads at 22. 6% versus 15. 0% for GWW. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EPAC or CAT or EMR or GWW more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Enerpac Tool Group Corp. (EPAC) is the more undervalued stock at a PEG of 0. 11x versus Emerson Electric Co. 's 4. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Enerpac Tool Group Corp. (EPAC) trades at 18. 7x forward P/E versus 37. 0x for Caterpillar Inc. — 18. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 2% to $161. 31.
08Which pays a better dividend — EPAC or CAT or EMR or GWW?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 1% for Enerpac Tool Group Corp. (EPAC).
09Is EPAC or CAT or EMR or GWW better for a retirement portfolio?
For long-horizon retirement investors, W.
W. Grainger, Inc. (GWW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 0. 8% yield, +462. 8% 10Y return). Both have compounded well over 10 years (GWW: +462. 8%, EPAC: +40. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EPAC and CAT and EMR and GWW?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CAT, EMR, GWW pay a dividend while EPAC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.